Argentina sets up national cancer institute
This article was originally published in SRA
Argentina's health ministry has created a National Institute of Cancer aimed at research activities related to the prevention, diagnosis and treatment of cancer1. Among other things, the new institute will support and co-ordinate research projects carried out by universities, hospitals, foundations and companies. It will also conduct basic and clinical research in its own laboratories and clinics.
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.